WCN26-9133 TREATMENT OUTCOMES AND RELAPSE PREDICTORS IN ADULT MINIMAL CHANGE DISEASE AT A TERTIARY CENTER IN ETHIOPIA

Minimal Change Disease (MCD), accounts for 10–15% of primary nephrotic syndrome cases in adults. Limited studies have examined its clinical characteristics, treatment outcomes, and relapse factors in adults, particularly in low-income countries like Ethiopia. This study aimed to assess the treatment outcomes, and factors associated with relapse among adult patients with MCD at St. Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia.